November 30, 2024 - 15:12

MARIETTA — Memorial Health System has announced the addition of Dr. Albeir Mousa, a highly qualified vascular surgeon, to its team at Marietta Memorial Hospital. Dr. Mousa brings a wealth of experience and expertise, enhancing the capabilities of the vascular team at MHS. His arrival is expected to significantly improve the level of care available to patients in the region.
Dr. Mousa is known for his proficiency in innovative vascular technologies and research, which will be instrumental in optimizing patient outcomes. His commitment to providing the highest quality of care aligns with the mission of Memorial Health System to deliver exceptional healthcare services to the community.
As he begins seeing patients, Dr. Mousa is poised to make a positive impact on the local healthcare landscape, ensuring that individuals in need of vascular care have access to the latest advancements and treatments available. The integration of his skills into the MHS team marks a promising development for patient care in the area.
January 31, 2026 - 23:19
Video Weekend health news roundupA relentless wave of arctic air gripping much of the nation is being blamed for a concurrent surge in influenza cases. Health officials report that the extreme cold is driving people indoors into...
January 31, 2026 - 17:47
The Sardine Fast: A Social Media Trend Under the Nutritional MicroscopeA new and extreme dietary trend is making waves online: the sardine fast. Promoted across social platforms, this regimen involves consuming only sardines for a set period, with claims of rapid...
January 30, 2026 - 19:23
'ChatGPT saved my life.' How patients, and doctors, are using AI to make a diagnosisHundreds of millions of people worldwide are now consulting AI chatbots, seeking answers for concerning symptoms. While medical professionals have long cautioned against unreliable online...
January 30, 2026 - 00:30
States are the next vaccine battlegroundAs the initial federal push for widespread COVID-19 vaccination gives way to long-term public health strategy, the focus of the vaccine debate has decisively shifted. The new battlegrounds are...